What is Breast Cancer Liquid Biopsy Market Scope?
Breast cancer remains the leading cause of premature deaths worldwide. Treatment relies on profiling a piece of biopsied tumour tissue. However, the ease of acquiring biopsy depends on patient condition and tumour accessibility. Liquid biopsy has been recently proposed as a promising detection method in oncology that is not only less invasive but also contributes to the early diagnosis of breast cancer. Here, the clinical utility of liquid biopsy as a tool for the early detection of breast cancer. With the introduction of novel techniques, the application of liquid biopsy has been enhanced, enabling the improvement of various aspects of breast cancer management including early diagnosis and screening, prediction of prognosis, early detection of relapse, serial sampling and efficient longitudinal monitoring of disease progress and response to treatment
The Breast Cancer Liquid Biopsy market study is being classified by Type (Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA), Extracellular Vesicles (EVs) and Other Circulating Biomarkers) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Breast Cancer Liquid Biopsy market throughout the predicted period.
QIAGEN N.V. (Netherlands), Roche Diagnostics (United States), Illumina, Inc. (United States), Bio-Rad Laboratories (United States), Myriad Genetics (United States), Menarini Silicon Biosystems (Italy), Cynvenio Biosystems, Inc. (United States), Genomic Health, Inc. (United States), Thermo Fisher Scientific Inc. (United States) and Fluxion Biosciences, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Biodesix, Inc. (United States), Guardant Health, Inc. (United States) and Isogen Life Science B.V. (Netherlands).
Analyst at AMA have segmented the market study of Global Breast Cancer Liquid Biopsy market by Type, Application and Region.
On the basis of geography, the market of Breast Cancer Liquid Biopsy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In June 2020 NeoGenomics launched Three Comprehensive Liquid Biopsy Tests Use in Patients With Cancer. The test is for advanced non–small cell lung cancer (NSCLC), all solid tumours, and certain breast cancer tumours, according to a press release.
Influencing Market Trend
- Government Funding & Initiatives
- Rising implementation of liquid biopsy owing to its advantages over the conventional biopsy expected to boost the liquid biopsy market growth
- The rising number of breast cancer cases across the globe
- The rapidly growing demand for non-invasive cancer treatment and the growing prevalence of cancer are the major factors that drive the growth of the Breast Cancer Liquid Biopsy market.
- Industry Investments and Initiatives
- High cost associated with the breast cancer liquid biopsy
- Lack of availability in emerging countries
Key Target AudienceBreast Cancer Liquid Biopsy Providers, Research institutes, Physicians and surgeons, Healthcare service providers and clinical research organizations and Market research and consulting firms
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.